TY - JOUR AU - Pivot, X; Gligorov, J; Müller, V TI - Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study JO - Lancet Oncol VL - 14 PY - 2013 DO - 10.1016/S1470-2045(13)70383-8 SP - 962 EP - 970 N1 - et al. ER -